3.09
-0.08(-2.52%)
Currency In USD
| Previous Close | 3.17 |
| Open | 3.14 |
| Day High | 3.26 |
| Day Low | 3.01 |
| 52-Week High | 10.16 |
| 52-Week Low | 2.08 |
| Volume | 101,352 |
| Average Volume | 702,067 |
| Market Cap | 7.87M |
| PE | -1.43 |
| EPS | -2.16 |
| Moving Average 50 Days | 3.3 |
| Moving Average 200 Days | 3.73 |
| Change | -0.08 |
If you invested $1000 in Biomerica, Inc. (BMRA) 10 years ago, it would be worth $429.17 as of August 18, 2025 at a share price of $3.09. Whereas If you bought $1000 worth of Biomerica, Inc. (BMRA) shares 5 years ago, it would be worth $48.65 as of August 18, 2025 at a share price of $3.09.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Home Use
GlobeNewswire Inc.
Aug 14, 2025 12:19 PM GMT
10-minute home test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerH. pylori linked to approximately 80% of gastric cancer cases; classified as a Class 1 carcinogen by the World Health Organiz
InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code
GlobeNewswire Inc.
Jul 02, 2025 12:08 PM GMT
PLA Code issuance by the American Medical Association CPT editorial panel marks a meaningful step toward attaining health insurance reimbursement and expanded patient access for inFoods® IBSinFoods® IBS provides personalized identification of food tr
Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica’s Team as Chief Commercial Officer
GlobeNewswire Inc.
Jun 26, 2025 12:19 PM GMT
Brings 20+ years of revenue growth leadership in laboratory testing, clinical diagnostics and global expansionLed successful organizational turnarounds and growth strategies at both Boston Heart Diagnostics and Genova DiagnosticsExtensive track recor